Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

What is the role of autologous stem cell transplant in multiple myeloma?

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 25.09.19
Views: 478
Rating:

Prof David Siegel - John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, USA

Prof David Siegel talks to ecancer at the International Myeloma Workshop 2019 about autologous stem cell transplant in multiple myeloma.

He recounts some of the discussion that occurred at this years conference between panelists and the audience debating whether autologous stem cell transplant still has a place in multiple myeloma treatment.

Prof Siegel gives some of the reasons as to why the consensus was generally 'yes'.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation